The Boiron Group today ranks as a global leader in homeopathy because of our steadfast commitment to research and development as it applies to the manufacture of homeopathic medicines.

Focus on R&D

Since 2005, we have invested an unprecedented level of effort in leading-edge homeopathic research. Our research programs, of which more than 80 are currently active, utilize the talents of university research teams, homeopathy practitioners, physicians and veterinarians from around the world. The four main thrusts of our R&D efforts are:

• Pharmacological research: Designed to prove the existence of the biological and physical effects of infinitesimal dilutions.
  Research involving infinitesimally small substances is particularly promising for homeopathy applications.

• Clinical research: Establish clinical evidence of the efficacy of homeopathic medicines and reconcile it with real-world findings.
  It is in this light that we are assessing the use of some of our medicines in the treatment of serious illnesses, in order to help diminish the side effects of more invasive treatment options.

• Pharmacoepidemiological research: Underscore the public’s interest in homeopathy.
  Several countries are now incorporating other considerations into overall treatment costs, including financial impacts, environmental impacts and social/human impacts.

• Therapeutic medical research: Better grasp the mechanisms at work in homeopathic medicines and explore new therapeutic horizons.